Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
The North Chicago–based drug firm AbbVie has struck a $30 million, 3-year research partnership with Harvard Medical School focused on coronaviruses and emerging pathogens. The collaboration will include immune system research as well as efforts to discover both small-molecule and antibody drugs. AbbVie is testing its Bruton’s tyrosine kinase inhibitor to help reduce cytokine storms in people with COVID-19 and is developing a monoclonal antibody that targets the novel coronavirus.
This article has been sent to the following recipient: